analysts and calls -- ML | Stock Discussion Forums

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical
analysts and calls -- ML

An SI Board Since September 2002

Posts	SubjectMarks	Bans
238	19	0

Emcee: scaram(o)uche	Type: Moderated

Introduction Compact

Go to reply# or date (mm/dd/yy):

Reply	Message Preview	From	Recs	Posted
38	LLY: Lilly (Eli) & Co (LLY; $68.45; B-1-7 to B-2-7) Price Target Achieved;	tom pope	-	6/27/2003
37	and now, the other twin - IDEC Pharmaceuticals (IDPH; $38.97; C-2-9) Biogen (BG	tom pope	-	6/25/2003
36	falling down on the job, this is from yesterday Biogen (BGEN; $43.80; C-2-9) BG	tom pope	-	6/25/2003
35	WYE Event We are upgrading Wyeth to Buy from Neutral based on the company’s acc	tom pope	-	6/19/2003
34	Biotechnology Profit Taking Likely Over; Biotechs Poised to Move Higher (Comment	tom pope	-	6/11/2003
33	Gilead Sciences Inc (GILD; $50.58; C-1-9) Raising ’03 & ’04 Estimates and Ta	tom pope	-	6/11/2003
32	NPSP <i>Morning Notes Summary – 14 May 2003 NPS Pharmaceuticals (NPSP; $2	tom pope	-	5/15/2003
31	This is from yesterday: <i>Amgen (AMGN; $60.18; C-1-9) BUY Amgen on Reimb	tom pope	-	5/8/2003
30	Astra Zeneca (Local AZNCF / ADR AZN; 2508p / $43:05; B-2-7/B-2-7 to B-1-7 / B-1-	tom pope	-	5/6/2003
29	Today OSI Pharmaceuticals (OSIP; $20.72; C-1-9) Higher Probability of Success f	tom pope	-	5/6/2003
28	And now AMGN. Sure wish I'd listened to them when they started yelling abou	tom pope	-	4/24/2003
27	a couple from ML: <i>Gilead Sciences Inc (GILD; $45.65; C-1-9) Strong Vir	tom pope	-	4/24/2003
26	ML: <i>Biotechnology Comment Available 1Q03 Earnings Preview • AMGN ($58.	tom pope	-	4/9/2003
25	Target is great, but..... stock has been a monster.... a little late. For	scaram(o)uche	-	4/3/2003
24	ML this a.m. Sepracor Inc. (SEPR; $15.97; C-2-9 to C-1-9) Upgrading to BUY; A B	tom pope	-	4/3/2003
23	And they follow up with this. I can't recall a biotech being an ML Focus sto	tom pope	-	3/10/2003
22	From ML - GILD <i>Gilead Sciences Inc (GILD; $36.50; C-1-9) Answers to th	tom pope	-	3/10/2003
21	ML this morning <i>NPS Pharmaceuticals Inc (NPSP; $17.36; C-1-9) The Catc	tom pope	-	3/3/2003
20	From ML this a.m. Amgen Inc (AMGN; $53.15; C-1-9) Analyst Meeting As Expected (	tom pope	-	2/26/2003
19	interesting take, in the face of a 25% decline. <i>NPS Pharmaceuticals (NP	tom pope	-	2/20/2003
18	a bit late, this is from Friday: Amgen (AMGN; $53.50; C-1-9) Prod Sales Strong;	tom pope	-	1/25/2003
17	Amgen (AMGN; $51.18; C-1-9) Amgen Reports Positive Enbrel Data for Psoriasis; Of	tom pope	-	1/17/2003
16	(Continued) Top Picks for 2003 Year Ahead: Top Biotech Picks for 2003 – AMGN, GI	tom pope	-	1/6/2003
15	#3 Idec Pharmaceuticals (IDPH; $33.93; C-2-9) Volatility Risk: High EPS (Dec):	tom pope	-	12/18/2002
14	#2 MedImmune (MEDI; $24.99; C-1-9) FDA Panel Recommends FluMist Approval (Comme	tom pope	-	12/18/2002

Go to reply# or date (mm/dd/yy):